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446a Tuesday, March 3, 2009several disease-causing mutations in ClC-5 translate into truncations of the
carboxy terminus (Ct), highlighting the significance of this region. The Ct in-
teracts with the scaffold protein NHERF2 (Naþ/Hþ exchanger regulatory fac-
tor 2) and leads to enhanced endocytic uptake of albumin by kidney cells
[Hryciw, D. et al. 2006]. This interaction occurs through the second PDZ do-
main of NHERF2 and an unknown binding site on the Ct of ClC-5 [Hryciw,
D. et al. 2006]. In the present study NHERF2/ClC-5 Ct interactions were con-
firmed and a putative internal PDZ binding motif TSII (residues 657-60) was
identified in the Ct. Mapping of this motif on the crystal structure of ClC-5
reveals it lies up-stream of a b-turn, a secondary structure element thought
to be critical for PDZ domain recognition of an internal motif [Hillier, B.
et al. 1999]. The strategic S658A mutation completely abolishes NHERF2
binding in vitro suggesting the PDZ binding motif was targeted. CD analysis
confirmed similar spectra between wildtype and S658A mutant, indicating
that this mutation does not lead to gross misfolding of the Ct. The disease mu-
tant R648X which removes this critical S658 abolishes NHERF2 interactions
providing further evidence the internal PDZ binding motif was targeted. Fu-
ture work will focus on identifying proteins interacting with the ClC-5/
NHERF2 complex and deciphering the role of this complex in renal endocy-
tosis. This work was supported by the Kidney Foundation of Canada operating
gant to C.B. and a NSERC studentship to L.W.
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Fibroblast Growth Factors (FGFs) belong to a large family of b-trefoil poly-
peptide growth factors and contain no disulfide binds. FGFs are involved in
various important biological processes such as development and maintenance
of cells. FGFs are about 154 amino acids long and are believed to share
a common core of 140 amino acids with 6 invariant proline residues. The
secondary structural elements in FGFs include 12 antiparallel beta-sheets ar-
ranged in to a beta-barrel motif. Critical analyses of the three-dimensional
structure of human acidic fibroblast factpr (hFGF-1) show that proline resi-
dues play a critical role in shaping the beta-barrel architecture of the protein.
In this context, using a site-directed mutagenesis approach, we examined the
effects of substitution of proline on the structure, stability and function of
hFGF-1. The stability of of the various proline mutants of FGF-1, were as-
sessed by differential scanning calorimetry, limited proteolytic digestion,
and urea-induced equilibrium unfolding. Conformational changes induced
in the various proline mutants of hFGF-1 have been studied using 1-ani-
lino-8-napthalene sulfonate binding, far UV circular dichroism, and multidi-
mensional NMR spectroscopy. The heparin and receptor binding affinities of
the hFGF-1 mutants were investigated by isothermal titration calorimetry.
The results of this study are expected to provide valuable information for a ra-
tional design of hFGF-1 with increased stability and enhanced cell prolifer-
ation activity.
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HIV-1 reverse transcriptase is a complex multi-subunit enzyme that converts
single stranded viral RNA into double stranded proviral DNA. This enzyme
possesses both DNA polymerase and RNase H activity. Structurally, RT is
composed of a 66 kD (p66) subunit and a 51 kD (p51) subunit that lacks an RN-
ase H domain. The homodimers retain DNA polymerase activity but only the
p66/p66 homodimer has RNase H activity. In solution, the enzyme exists as
an equilibrium mixture of the heterodimer p66/p51, two homodimers p66/
p66 and p51/p51 and the two monomers. The nonnucleoside reversible inhib-
itor (NNRTI) efavirenz enhances dimerization of p66/p51, p66/p66, and p51/
p51. The drug binds both monomeric and dimeric RTs. However, structural
changes induced by drug binding are unknown. A combination of hydrogen
deuterium exchange and mass spectrometry is used to probe the solution struc-
ture of RT monomers in the presence and absence of efavirenz. Here we dem-
onstrate that p66 and p51 monomers have similar solution structures, which
resemble the p51 subunit in the crystal structure of p66/p51 heterodimer. After
drug binding the solution structure of the monomers changes to resemble the
p66 subunit in the crystal structure of the heterodimer. We also show that res-
idues in the drug binding pocket of p66/p51-efavirenz complex are affected by
drug binding to monomer.2302-Pos Board B272
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High-affinity binding of extracellular protein ligands belonging to the tumor
necrosis factor (TNF) superfamily to their conjugate transmembrane cell sur-
face TNF receptors initiates the extrinsic signaling cascade that results in apo-
ptotic cell death. Intriguingly, despite a high-degree of structural homology
among the family of ligands and receptors, the ligand binding is both high-af-
finity and has high-specificity. As yet, it is poorly understood what confers this
specificity. Starting from the crystal structures for the TRAIL-death receptor 5
and LTa-TNF receptor 1 complexes, we used all-atom molecular dynamics
simulations to investigate the stabilizing interactions between these ligand-re-
ceptor pairs. Additionally, we simulated both complexes with destabilizing
point mutations. The simulation results yield insight into published experimen-
tal data as well as the underlying mechanism of high affinity ligand-receptor
binding.
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Fibroblast growth factors (FGFs) are heparin binding proteins that help regulate
key cellular processes such as wound healing and differentiation, cell prolifer-
ation, cell migration, morphogenesis, and angiogenesis. The FGF signaling is
generated by the binding of the ligand (FGF) to the extracellular domain of
the FGFR, this binding induces dimerization of FGFR, which is an essential
step in FGF signaling. Fibroblast growth factor receptor (FGFR) extracellular
domain consists of three Ig domains D1, D2, and D3. Between the Domains
D1 and D2 is a short span of acidic residues called the ‘‘acid box’’. The D1-
D2 linker is thought to play a role in regulation of FGF interaction with
FGFR. Many of the FGF binding sites can be found on the extracellular D2 do-
main of the receptor. It is believed that ‘‘acid box’’ can regulate FGF binding to
FGFR. The ‘‘acid box’’ can mimic heparin like compounds and bind at the hep-
arin binding sites located on the surface of the D2 region of FGFR. In the pres-
ent study, we synthesized a twenty-eight amino acid box region peptide and
studied its interaction with D2 domain of FGFR using various biophysical tech-
niques including multidimensional NMR spectroscopy. Equilibrium unfolding
experiment monitored steady state fluorescence, far-UV circular dichrosim and
proteolytic digestion experiments reveal that acid box binds to D2 domain very
weakly. Two-dimensional nuclear magnetic resonance 1H-15N HSQC experi-
ments show that the acid box binds to the FGF-1 and heparin binding sites in
the N-terminal end of the D2 domain of FGFR. Our results clearly show that
the acid box peptide binds to the ligand binding domain of the fibroblast growth
factor receptor.
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S100A13 is a calcium binding chaperone protein, known to be involved in the
non-classical export of signal peptide less proteins such as fibroblast growth
factor (FGF-1) and interleukin-1a across the cell membrane. It has also been
shown that the interaction of S100A13 with Annexin II, which exhibits an in-
ducible flip-flop mechanism across the cell bilayer, helps the multiprotein re-
lease complex to traverse the membrane bilayer. The interaction of S100A13
and annexin II has been characterized using various biophysical techniques
including multidimensional NMR spectroscopy. Results of the Isothermal titra-
tion calorimetry (ITC) experiments show that holo-S100A13 exhibits preferen-
tial binding to annexin II with high affinity in the micro molar rang compared to
apo-S100A13. Equilibrium guanidine hydrochloride denaturation monitored by
steady-state fluorescence and limited trypsin digestion analysis reveals holo-
S100A13 is significantly stabilized upon binding to annexin II peptide
compared to apo-S100A13. ANS (8-anilino-1-napthalene sulfonate) binding
experiments indicates that the presence of annexin II peptide does not increase
the solvent availability of hydrophobic residues in holo-S100A13. Availability
of the solvent-exposed hydrophobic surface(s) in apoS10013 does not facilitate
its interaction with the annexin II peptide, which is unique characteristic of
S100A13. 1H-15N- HSQC NMR experiments reveal that the binding site of an-
nexin II peptide on holo-S100A13 is modestly different from other S100/An-
nexin interactions. S100 proteins typically interact with more than one Annexin
protein. In order to define the specificity of S100A13 for Annexin 2, the inter-
action of S100A13 with other Annexin peptides was characterized and data
Tuesday, March 3, 2009 447acharacterizing these interactions will be presented. Finally, defining the inter-
action between S100A13 and Annexin 2 peptide will give much needed insight
into the non-classical release of the signal peptide-less protein Fibroblast
Growth Factor-1
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Connexins are integral membrane proteins that oligomerize to form intercellu-
lar gap junction channels. These channels allow the passage of ions, small mol-
ecules, and second messengers that are essential for the coordination of cellular
function. Many factors have been identified to regulate the channel gating of
the major cardiac connexin, connexin43 (Cx43) and our laboratory has focused
on pH-regulation, which is a cause of ischemia-induced arrhythmias. Our pre-
vious studies have suggested that regulation of Cx43 channels results from the
association of the carboxyl-terminal domain (Cx43CT), acting as a gating par-
ticle, and the cytoplasmic loop domain (Cx43CL), acting as a receptor for the
gating particle. Recently, we have identified a synthetic peptide, RXP-E (30-
mer peptide containing a RXP sequence specifically recognized by Cx43CT,
where X represents any amino acid, and R and P correspond to arginine and
proline) that interacts with the Cx43CT and can prevent closure channel. The
question remains as to whether this peptide is involved in the disruption of
the Cx43CT/Cx43CL interaction. Using NMR, we investigated the changes
in the structure of Cx43CT with RXP-E and identified the binding site in the
first half of the Cx43CT. The identification of this new specific binding domain
was furthermore confirmed by mutagenesis. Additionally, we studied the inter-
action of Cx43CT with Cx43CL and identified a similar binding region as
RXPE, confirming the potentiality of our peptide to act as a ‘‘scaffold’’, thereby
holding the channels in its open state and reducing life threatening arrhythmias.
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In recent years, scientific community has paid great attention to characterize the
protein folding and unfolding processes. Interestingly they can exhibit wide
range of structures like oligomers and aggregates. In the present work, acidic
fibrillation of bovine alpha-lactalbumin (a-LA) was studied in presence and ab-
sence of natural small nontoxic compounds at 37C in 10mMTris/10mM NaCl
buffer, pH 2.2.
Various techniques including, ThT intensity, Congo Red absorbance, far- and
near-UV, circular dichroism (CD) and intrinsic fluorescence spectroscopy,
ANS intensity, Gel filtration, TEM microscopy, were applied to characterize
the inhibitory effect of them.
Congo Red clearly demonstrated the inhibitory effect of one of these com-
pounds in amyloidogenesis pathway. The formation of beta structures was
evidently demonstrated by CD and the instability of a-LA by intrinsic fluores-
cence and ANS intensity through analysis of nucleation step is confirmed. To
give more assurance, one of these compounds was added at different times in-
cluding 0, 12, 18, 24 and 48 hours. Our data indicated that it does not play an
important role in the stability of native a-LA. However its addition after 18
hours inhibited amyloid fibrillation.
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Influenza virus binds via its envelope protein hemagglutinin (HA) sialic acid
(SA) residues of glycoproteins on the plasma membrane of the host cell. The
affinity of a single HA-SA pair is low (103 M1) compared to the overall affin-
ity between virus and cell surface caused by multiple simultaneous interactions.
For example, the affinity between virus and erythrocytes - serving as a model
for a host cell - is about 1013 M1. Multivalency is ubiquitous in biology and
can dramatically enhance affinities. We use synthetic polymers with multiple
sialic acid moieties to investigate their inhibitory effect on virus binding andfusion. The aim of this study is to gain insights into the molecular mechanism
and the effect principles of multivalent inhibitors. Furthermore we aim to mea-
sure the accurate affinity between a virus particle and the target erythrocyte
membrane by using a new developed optical tweezers system. With this ap-
proach we are able to explore the action of multivalent inhibitors on the single
molecule level. Furthermore, we study binding of labelled virus particles to hu-
man erythrocytes using fluorescence activated cell sorting (FACS). The fusion
activity is examined by detection of fluorescence de-quenching of R 18 labeled
viruses attached to human erythrocyte ghosts.
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The majority of human immunodeficiency virus-1 (HIV-1) infections across
the world result from non-B clades. CRF01_AE is predominantly seen in
Southeast Asia and the protease differs by ~10% when compared to the clade
B protease. Polymorphisms in CRF01_AE are often associated with drug resis-
tance in the clade B protease. CRF01_AE protease has been observed to de-
velop the unique N88S mutation in response to nelfinavir (NFV) therapy which
is not commonly seen in clade B protease. We present here, structural and bind-
ing thermodynamic data on CRF01_AE protease in order to explain how se-
quence polymorphisms within CRF01_AE protease might affect its activity
as well as to explain the altered NFV resistance pathway observed in
CRF01_AE. The crystal structure of HIV-1 CRF01_AE N88S protease in com-
plex with Darunavir (DRV) was determined to a resolution of 1.76 A˚ and was
compared with the clade B protease in complex with DRV. The CRF01_AE
structure shows a significant change in the flap hinge region of the protease
when compared to the clade B structure. The Ser88 side chain in the
CRF01_AE structure is involved with a novel network of hydrogen bonds
and interacts with the side chain of Asp30. This likely disrupts a critical hydro-
gen bond required for NFV binding. Binding constants and thermodynamic pa-
rameters for CRF01_AE and clade B protease were determined by isothermal
titration calorimetry (ITC). Calorimetric data indicate that wild type
CRF01_AE protease has ten fold and two fold weaker to NFV and DRV respec-
tively when compared to clade B protease. This weakened affinity may permit
the alternative pathway for NFV resistance via N88S, which is a mutation out-
side the active site.
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In Eubacteria, the ATPase SecA transports secretory proteins across the inner
membrane using the membrane embedded channel, SecYEG. SecA drives the
preprotein through the channel in an ATP dependant manner that promotes a se-
ries of conformational changes associated with the insertion and deinsertion of
a region of SecA during the translocation cycle. To gain additional insight into
the interactions between SecA and SecYEG, an in vivo sulfhydryl labeling
technique was developed to probe monocysteine SecA mutants through the
channel during protein translocation using N-(3-maleimidylpropionyl)biocytin
(MPB). Our lab demonstrated multiple residues of SecA that are exposed to the
trans side of the membrane through the SecYEG channel. These residues,
which were located throughout most domains of SecA, resided on a single
face within the Bacillus subtilis SecA crystal structure. This provided some in-
sight into the regions of SecA that are in fluid contact with the channel. Inter-
estingly, two residues located on the opposite side of the labeled face of SecA in
the nucleotide-binding domain I (NBD-I) also labeled. In the present study, the
NBDI domain was further investigated to determine if there were other residues
in fluid contact with the SecYEG channel. Additional monocysteine SecA mu-
tants were created in the NBDI domain and analyzed using the same method-
ology. After looking at the crystal structure with the newly labeled residues, the
labeled face of SecA seemed less apparent. These results emphasize the dy-
namic nature of SecA and identified regions of SecA that may interact with
the channel. The NBDI mutants will be further analyzed using an in vivo photo-
crosslinking technique.
